May 03, 2021 - Despite the trials and upsets of the coronavirus in 2020, ClearCam blazed a trail to maximize surgical vision and skill with over 125 human trials for its laparoscopic lens cleaning Kelling™ device recently. Just after the one-year mark of the shutdown of the US economy due to COVID-19, ClearCam completed its clinical pilot of the groundbreaking tool. The Kelling device allows a surgeon to clean the scope of fat, condensation, blood, and other surgical debris, without removing it from the patient’s body, to maintain a perfectly clear optical visual field.
FDA cleared for use in humans in February 2020, Kelling is an in-vivo laparoscopic lens wiper made out of over-molded Medical-Grade Silicon with precise angles, smooth lens contact, and a simple easy-to-use mechanical design. It allows surgeons to maintain their visual field throughout the case to focus solely on the patient and procedure, and to utilize today’s high resolution and advanced minimally-invasive technologies as they are meant to be used.
With over a dozen hospitals across the country using the Kelling device, among the physicians is Carlos Garcia-Cantu, MD, of Doctor's Hospital at Renaissance in the Rio Grande Valley of Texas. He says, "I would use this every time I had a case that required a 5mm scope. It worked really well."
During a typical one-hour abdominal laparoscopic procedure, surgeons may need to remove the scope potentially a dozen times to clear the lens. Kelling is a mechanical, efficient and disposable in-vivo laparoscopic lens cleaner that eliminates the need for removal.
“Our dedicated process of identifying opportunities to perfect the laparoscopic process during the 100 cases has paid off, to allow surgeons to use Kelling effectively and successfully, without cleaning interruptions,” states Dr. John Uecker, general surgeon and CEO of ClearCam, Inc. Dr. Uecker co-founded the device company after having performed close to 350 laparoscopies a year and encountering the consistent issue of needing to clean the lens. “A good surgeon is a surgeon that isn’t frustrated by poor vision due to a blurred scope,” he adds.
Laparoscopic procedures are used in both pediatric and adult cases. "I was pleasantly surprised how well it worked. It was quite simple to use," says Jonathan Espana, MD, of Texas Children's Hospital in Houston, Texas.
ClearCam is passionate about introducing more efficient and productive surgeries, with few abdominal surgical procedures today evading the laparoscopic approach. And with the operating room of tomorrow moving toward more precise and advanced robotic-assisted surgeries, ClearCam has an answer with the current development of “Galaxie,” to address the same issue of scope cleaning in the robotic surgery market.
"This device really helps when I have to work deep in the peritoneal cavity," says Scott Thomas, MD, of Baylor Scott and White Medical Center in Austin, Texas.
About ClearCam™ Inc.
The mission of ClearCam™ Inc. is to improve laparoscopic surgery patient outcomes by reducing risk, easing surgeon frustration, shortening procedure times and lowering costs by maximizing the visualization platform. The Kelling™ device has been used in multiple operations in over a dozen hospital systems across the country in gynecologic, thoracic, pediatric and general surgery cases.
ClearCam is a proud affiliate/alum of the Dell Medical School at the University of Texas at Austin, The Cockrell School of Engineering at the University of Texas at Austin and their Innovation Center, Texas Venture Labs, The Texas Health Catalyst, The Austin Technology Incubator, and the MedTech Innovator Accelerator. Currently ClearCam has labs and offices at MedtoMarket (www.medtomarket.com) and a cleanroom at the ACC Bioscience Incubator in Austin, Texas. They can be contacted at https://www.clearcam-med.com/contact/.
For Media Inquiries: Alecia Ormsby - aormsby ( @ ) clearcam-med dot com – 512-663-8999
Contact Information
Alecia Ormsby
Clearcam
2101 E. St. Elmo Rd., Bldg 1, Ste 100
78744
Voice: 512-663-8999
